Trial Failure Still Yields Insights for Uterine Leiomyosarcoma

Experts weigh in on valuable findings that can be gleaned despite the fact that the phase III trial did not generate clinically meaningful results.

Source: CancerNetwork - January 10, 2019 Category: Cancer & Oncology Authors: Christina Bennett, MS Source Type: news